When Your Patient Needs New Glasses Every Day

Dominique Prétot; Katrin Marie Engesser; Torsten Schlote; Maria Della Volpe

doi:10.1055/a-2004-5504

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2023; 240(04): 566-568
DOI: 10.1055/a-2004-5504

Der interessante Fall

When Your Patient Needs New Glasses Every Day

Wenn die Patientin jeden Tag eine neue Brille benötigt

Dominique Prétot

¹Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland

,

Katrin Marie Engesser

¹Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland

,

Torsten Schlote

¹Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland

²Ophthalmology, Ambimed Eye Clinic, Basel, Switzerland

,

Maria Della Volpe

¹Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1978; 22: 9-35
2 Feldman BH, OʼKeefe GD, Salcedo HR. et al. Vogt-Koyanagi-Harada Disease. Accessed September 27, 2022 at: http://eyewiki.aao.org
3 Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2021; 228: 205-211
4 Rao NA, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol 2007; 27: 195-199
5 Rathiam SR, Vijayalakshmi P, Namperumalsamy P. et al. Vogt–Koyanagi–Harada syndrome in children. Ocul Immunol Inflam 1998; 6: 155-161
6 Paredes I, Ahmed M, Foster C. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
7 Lai TYY, Chan RPS, Chan CKM. et al. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 2009; 23: 543-548
8 Biswas J, Rao NA. Management of Intraocular Inflammation. In: Ryan SJ. ed. Retina. Vol. 2. St. Louis: Mosby-Year Book; 1994: 1061-1069
9 Rao NA, Blackman HJ, Franklin RM. et al. Intraocular Inflammation and Uveitis. In: Course Book. Basic and Clinical Science Course 1998 – 1999. San Francisco: American Academy of Ophthalmology; 1998: 76-79
10 Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
11 Yang P, Wang H, Zhou H. et al. [Therapeutic regimen in Vogt Koyanagi Harada syndrome]. Zhonghua Yan Ke Za Zhi 2002; 38: 196-199